Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
A longevity startup has dosed its first patient with a drug to reverse age-related sight loss. Life Biosciences is testing its ER-100 drug, which has been shown to restore vision in monkeys, for safety and side effects in a study of around 18 adults over the next year. It will be targeting patients with glaucoma … Read more